Profitability Metrics

Gross Margin
46.21%
Operating Margin
31.51%
Net Margin
23.97%

Efficiency Metrics

Revenue per Expense Ratio
1.46
R&D as % of Revenue
8.02%

Earnings Quality

EBITDA Margin
34.44%
Income Tax Rate
24.09%
EPS
6.1100000000

Balance Sheet Analysis

Current Ratio
0.87
Cash Ratio
0.37
Working Capital
$-23.41B
Debt to Equity
1.87
Debt to Assets
29.22%
Equity Ratio
15.60%

Cash Flow Analysis

Operating Cash Flow Ratio
30.24%
Free Cash Flow Ratio
27.83%
CapEx to Revenue
2.42%
Dividends Paid
$15.23B
Stock Buybacks
$94.95B
Total Shareholder Returns
$110.18B
Cash Position Change
-2.58%

Key Takeaways (2024 FY)

  • Increased dividend payments by 4.04%
  • Increased R&D investment by 4.86%

Detailed Growth Metrics

Core Performance

Revenue
2.02%
Net Income
-3.36%
EPS
-0.81%
Operating Income
7.80%

Operational Efficiency

R&D Expenses
4.86%
SG&A Expenses
4.67%
Operating Cash Flow
6.98%
Free Cash Flow
9.26%

Balance Sheet Health

Assets
3.52%
Debt
-4.01%
Book Value per Share
-5.97%
Inventory
15.08%

Shareholder Returns

Dividends per Share
4.04%
Shares Outstanding
-2.54%

Long Term Trends

3Y Revenue/Share
16.35%
5Y Revenue/Share
80.93%
3Y Dividend/Share
14.62%
5Y Dividend/Share
29.89%